Jiaoyue Hu

xiamen university

H指数:19

被引数:1,210

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted degradation of VEGFR2 via PROTAC encapsulated by cRGD-liposome reverses pathological corneal neovascularization

通过cRGD-脂质体包封的PROTAC靶向降解VEGFR2逆转病理性角膜新生血管

Biomaterials

IF12.9

2026-09-010

PRE

Global burden of early-onset mental disorders in adolescents and young adults: a systematic analysis based on the Global Burden of Disease study 2021

青少年和年轻成年人早期发病精神障碍的全球负担：一项基于2021年全球疾病负担研究的系统分析

BMC Psychiatry

IF3.6

2026-04-040

OAAI

Advances and challenges of targeted protein degradation in ophthalmology: Future directions and therapeutic potential

靶向蛋白降解在眼科学中的进展与挑战：未来方向与治疗潜力

Materials & Design

IF7.9

2025-09-160

OAAI

Light-emitting diode-derived blue light overexposure accelerates corneal endothelial cell aging by inducing abnormal ROS accumulation

LED衍生的蓝光过度暴露通过诱导异常ROS积累加速角膜内皮细胞衰老

photochemistry and photobiology b biology

IF0

2025-09-010

PRE

Prostaglandin F2α exacerbated dry eye by promoting lacrimal gland fibrosis progression through the activation of the RhoA/ROCKs signaling pathway

前列腺素F2α通过激活RhoA/ROCKs信号通路，促进泪腺纤维化进展，从而加剧干眼症。

ocular surface

IF0

2025-07-180

OAAI

药物相关视觉模糊：美国食品药品监督管理局不良事件报告系统数据库的研究发现

European Journal of Pharmacology

IF4.7

2025-06-070

PRE

Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database

药物相关性青光眼: 基于食品和药物管理局不良事件报告系统数据库的真实世界研究

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

IF5.6

2024-10-251

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database

THERAPEUTIC ADVANCES IN DRUG SAFETY

IF3.4

2024-10-160

OAAI

Cell death pathways in dry eye disease: Insights into ocular surface inflammation

干眼症中的细胞死亡途径: 眼表炎症的见解

OCULAR SURFACE

IF5.6

2024-10-010

PRE

Revamping anti-cGAS-STING therapy via an injectable thermo-responsive supramolecular hydrogel for pathological retinal angiogenesis

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF11.9

2024-10-010

Multifaceted mitochondrial as a novel therapeutic target in dry eye: insights and interventions

CELL DEATH DISCOVERY

IF7

2024-09-061

OAAI

Real-World Large Sample Assessment of Drug-related Dry Eye Risk: Based on the FDA Adverse Event Reporting System Database

ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY

IF4.5

2024-09-012

OAAI

Unleashing Novel Therapeutic Strategies for Dry Eye: Targeting ROS and the cGAS-STING Signaling Pathway with Tetrahedral Framework Nucleic Acids

释放干眼症的新治疗策略: 用四面体框架核酸靶向ROS和cGAS-STING信号通路

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-07-281

Berberine ameliorate inflammation and apoptosis via modulating PI3K/ AKT/NFκB and MAPK pathway on dry eye

小檗碱通过调节PI3K/ AKT/nf κ b和MAPK通路改善干眼炎症和凋亡

PHYTOMEDICINE

IF8.3

2023-12-0112

PRE

The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation

线粒体DNA的cGAS-STING通路依赖性传感介导眼表炎症

Signal Transduction and Targeted Therapy

IF52.7

2023-09-210

OAAI

Functional engineered exosomes mitigate pathological ischemic retinopathy through a dual strategy of inflammatory microenvironment modulation and angiogenic factor control

MATERIALS & DESIGN

IF7.9

2023-09-011

OAAI

MAP4Ks inhibition promotes retinal neuron regeneration from Muller glia in adult mice

MAP4Ks抑制促进成年小鼠Muller胶质细胞的视网膜神经元再生

NPJ REGENERATIVE MEDICINE

IF6.5

2023-07-138

Icariside II alleviates ischemic retinopathy by modulating microglia and promoting vessel integrity

JOURNAL OF FUNCTIONAL FOODS

IF4

2023-05-015

OAAI

Can the cGAS-STING Pathway Play a Role in the Dry Eye?

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-2412

OAAI

Sleep deprivation induces corneal epithelial progenitor cell over-expansion through disruption of redox homeostasis in the tear film (vol 17, pg 1105, 2022)

睡眠剥夺通过破坏泪膜中的氧化还原稳态来诱导角膜上皮祖细胞过度扩张 (第17卷，1105页，2022页)

STEM CELL REPORTS

IF5.1

2022-06-011

OAAI

Jiaoyue Hu

个人简介

教育背景

工作经历

荣誉奖项

研究方向